On the recordFebruary 3, 2016
I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into one average sales price calculation and payment code.
Source
congress.govJoe Pitts: “I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into…”
Editor's note · Context
Pitts expresses concern over CMS's payment policy for biosimilars potentially harming market entry.
Share
More from Joe Pitts
Sep 13, 2016
Because of the Affordable Care Act, now over 20 million people in this country who were in that situation literally overnight are no longer in that situation.
Dec 6, 2016
The jurisdictional grab serves only to shield catfish farmers against competition at the expense of U.S. consumers.
Sep 13, 2016
I for one in a portion of my life when I was a boy lived in a household where we didn't have access to health care.
Other voices in this conversation
